ArticleFrontiers in oncology2023
Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits.
Yinjie Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it